The move, however, was met with strong opposition from compounders, which sued the regulator under the banner of the Outsourcing Facilities Association (OFA) trade group
Supplied as oral capsules for research use
Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia
T.AuvrayF.RfrgiersM.HirstJ
Applications by Clinical Target The same BPC-157 dosage can serve different purposes depending on how it is administered and what it is combined with
Purchaser Restrictions Purchaser must be a qualified researcher at an accredited institution or licensed research facility This product may not be sold or redistributed to individual consumers, wellness clinics, health food stores, or retail establishments Not intended for human or animal consumption, diagnostic use, or therapeutic application Institutional affiliation and research purpose will be verified prior to order fulfillment Distribution is limited to qualified research use in compliance with applicable federal and state law